Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Rein Therapeutics announced it will present a late-breaking poster on LTI-03, its novel inhaled peptide therapy for idiopathic pulmonary fibrosis, at the European Respiratory Society (ERS) 2026 Congress. The presentation will detail data from the RENEW Phase 2 trial evaluating safety and efficacy of LTI-03, which aims to inhibit lung fibrosis and p…
Nautilus Biotechnology announced a pioneering peer-reviewed study published in Nature Methods demonstrating its Iterative Mapping technology's ability to quantify distinct tau proteoforms at single-molecule resolution. This novel measurement reveals disease-associated ordered modification patterns crucial for understanding Alzheimer's disease and r…
Hurco Companies, Inc. reported a net income of $2.314 million for Q3 fiscal 2026, a significant turnaround from a net loss in the same period last year. Sales increased 3% year-over-year, driven by higher machine sales in the U.S. and Asia Pacific regions and a stronger product mix. Gross margin expanded by 800 basis points to 28%, aided by cost co…
Alumis Inc., a late-stage biopharmaceutical company specializing in next-generation targeted therapies for immune-mediated diseases, announced its participation in several prominent investor conferences throughout September 2026. The company plans to present updates on its pipeline, including oral TYK2 inhibitors envudeucitinib and A-005, targeting…
OFA Group (Nasdaq: OFAL) announced that its AI-powered Building Information Modeling platform, QikBIM, has rapidly gained over 281,000 views and thousands of new followers within 90 days of launch. The platform reached nearly 187,000 architecture, engineering, and construction professionals in an eight-day paid campaign, significantly exceeded indu…
Iovance Biotherapeutics, a biotechnology company specializing in tumor infiltrating lymphocyte (TIL) therapies for cancer, announced that its senior leadership will present at the Wells Fargo 21st Annual Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. These presentations are part of the company's ongoing effo…
Intellia Therapeutics, a clinical-stage biopharmaceutical company specializing in CRISPR gene editing, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026. The presentation will be webcast live and available for replay on the company's website.
Lululemon shares plunged after management revised its outlook, leaving the stock cheaper on valuation metrics but facing a meaningful earnings reset. With guidance showing mid-single-digit full-year revenue declines and a steeper near-term drop, the case to buy immediately is speculative rather than definitive.
Equifax stock plunged in pre-market trading after the Federal Housing Finance Agency director accused the major credit bureaus of overcharging consumers, ordered Fannie Mae and Freddie Mac to approve VantageScore 4.0 for all mortgage lenders, and raised the possibility of allowing lenders to obtain reports from only two of the three major bureaus. …
Critical Metals (CRML) is often discussed as a pure rare-earth commodity bet. That framing misses the more important point: Tanbreez and recent Greenland moves create a strategic midstream bottleneck that could rerate the stock well ahead of production. This trade targets a mid-term rerating driven by strategic deals, government approvals and tight…
Clearmind Medicine, a clinical-stage biotech company primarily focused on neuroplastogen therapeutics, announces an acquisition of a 51% stake in Charging Robotics, a company developing wireless EV charging solutions for automated parking and autonomous vehicles. The acquisition involves a $2.5 million purchase plus a $1.5 million loan with 4% inte…
Broadcom is facing margin compression that has weighed on the stock, but underlying secular drivers - AI datacenter demand, networking upgrades, and sticky software revenue - point to outsized revenue growth ahead. This trade idea outlines a long entry, target, stop, catalysts to watch, and the risks that could derail the thesis.
Quantum Cyber N.V., a Nasdaq-listed defense technology company, announced a call for qualified manufacturing partners and applied-R&D organizations to develop a prototype of its quantum-photonic antenna front-end, aimed at enabling resilient, frequency-agile communications for unmanned aerial systems (UAS) in contested environments. This initiative…
Glass House Brands Inc., a fast-growing US cannabis company focused on the California market, will participate in three investor conferences in New York City during September 2026, including ATB Cormark Capital Markets, Lake Street Capital Markets, and H.C. Wainwright conferences. Management will conduct 1-on-1 meetings and present company overview…
The Women’s Protection Units (YPJ), once prominent in the campaign against Islamic State, are in negotiations with Syria’s interior ministry to preserve an organised combat role after the U.S.-backed Syrian Democratic Forces (SDF) were dissolved and the country’s defence structures were reshaped under a new government. YPJ leaders say they want the…
ByteDance has arranged a $29.6 billion loan from a syndicate of almost 30 banks, expanding an initial $20 billion target after strong lender demand. The dollar-denominated, unsecured facility carries a three-year initial term with options to extend and is intended for general corporate uses, with an emphasis on supporting the companys artificial i…
Morgan Stanley downgraded Daimler Truck Holding AG from "overweight" to "equal-weight" while increasing its price target to €50 and lifting 2027 and 2028 EPS forecasts. The firm described the move as tactical rather than a change in the company’s fundamentals, arguing that the broader truck cycle is around nine months past the North American Class …
Fair Isaac Corporation shares tumbled in pre-market trading after FHFA Director Bill Pulte directed Fannie Mae and Freddie Mac to immediately approve all mortgage lenders to use VantageScore. The move broadens a prior limited pilot and directly challenges FICO's dominant role in mortgage-originations scoring, a key driver of its Scores revenue grow…
Futures tied to Canada's main equity gauge held flat Friday morning, pausing after a strong rally the day before. Markets are balancing a commodity-led rebound in materials and mining against ongoing cross-border trade concerns and energy-driven inflationary pressure, following the Bank of Canadas decision to keep its policy rate unchanged.
Futures on Canada’s benchmark S&P/TSX index were subdued on Friday as investors waited for U.S. and Canadian employment reports that could influence expectations for central bank policy. Trading volumes were light, with markets parsing mixed inflation signals, divergent Fed commentary and geopolitical pressures on oil.
FICO, Equifax and TransUnion shares fell sharply in early trading after a U.S. housing official directed Fannie Mae and Freddie Mac to approve VantageScore for all lenders. The directive, announced by the Director of Federal Housing, follows an earlier move to accept VantageScore and comes alongside comments criticizing credit reporting firms for o…
Zenas BioPharma, a clinical-stage biopharmaceutical company focused on therapies for autoimmune and inflammatory diseases, announced upcoming presentations at three major healthcare investor conferences in September 2026. The company highlighted its lead product candidates, obexelimab and orelabrutinib, and discussed its approach to developing trea…
VERAXA Biotech AG announces the immediate appointment of Raju Willener as Chief Financial Officer. Mr. Willener brings over 30 years of global financial leadership experience, including in corporate finance, M&A, and capital markets, across the biopharmaceutical sector. He will support VERAXA's strategic capital allocation and growth initiatives as…
Instinct Bio provided an operational update announcing progress on its GENRÊVER CLINIC site development in Jakarta, targeting a December 2026 opening, along with subscription pricing tiers. The company is also advancing product development collaborations with Invitrx Therapeutics in the US and PT Parva Candela in Indonesia to manufacture GENRÊVER-b…
POET Technologies announced its participation in the 2026 China International Optoelectronic Expo (CIOE) and the Infostone Optical Communication and Market Technology Conference (IFOC), where it will present its latest advancements in wafer-level chip-scale packaging technology for high-power optical interconnects. The company highlighted its progr…
